Clinical Trials on Vaso-occlusive Crisis in Italy
Total 0 results
Nothing found
Sponsors and Collaborators
- MingSight Pharmaceuticals Pty Limited
- Kawin Technology Share-holding Co., Ltd.
- Montreal Neurological Institute and Hospital
- New York State Health Foundation
- Medtronic Atrial Fibrillation Solutions
- Wushan County People's Hospital
- John Granton
- Zahra Rabbani Khah
- CTC Bio, Inc.
- Northern California Melanoma Center
- The Third Hospital of Changsha
- Honda R and D Americas, Inc.
- Jeffrey W. Clark, MD
- Marilia Medicine School
- European Network For Smoking and Tobacco Prevention
- Jeffrey Rudolph
- Rex Bionics Plc
- Health Parametrics Inc.
- Mitchell Scheiman
- Ionis Pharmaceuticals
- View Full List
Medical Conditions
- HDT-AHCT
- Brain MRI
- Pancreatic Neoplasms
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Advanced Esophageal Cancers
- Renal Cancer Metastatic
- Ascaris Suum
- Pregnancy-Related Condition, Unspecified
- Metastatic Spine Lesions
- Primary Generalized Dystonia
- LSIL
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Periferal Arterial Occlusive Disease, PAOD
- Locally Advanced NSCLC
- H.Pylori Infection
- Waldenstrom's Macroglobulinemia Recurrent
- Liver Hemangioma
- Fasting, Diet, Chemotherapy, Toxicity
- Hyperthyroidism, Autoimmune
- ACTH-Secreting Pituitary Adenoma
- View Full List
Drug Interventions
- Fludarabine
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- 200 µg doxorubicin-containing MNA
- Bendamustine
- Rifaximin
- Levcromakalim
- ESK981
- Levobupivacaine, clonidine
- CKD-519
- Toripalimab plus Anlotinib
- Pentostatin
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- AZD7798
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Hydroxychloroquine
- Ombrabulin (AVE8062)
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Postoperative analgesia management
- Nimotuzumab
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Congo
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Philippines
- Contract Research Organizations in Poland
- Contract Research Organizations in Romania
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Senegal
- Contract Research Organizations in South Korea
- Contract Research Organizations in Sweden
- CRO list by country